ASP is an advanced materials company dedicated to developing technology and processes designed to produce and enrich isotopes used in multiple markets, which include Nuclear Medicine and therapeutics, green energy generation, and quantum computing.
Our initial focus is to utilize our proprietary ASP technology to construct, commission, and later produce commercial amounts of highly enriched isotopes for the Nuclear medicine market at our plants located in South Africa. We believe that the isotopes we may develop using the ASP technology have significant potential advantages to the end user, as well as commercial advantages due to companies’ Modular, cost-effective, and environmentally friendly processes.
We may also seek to use the ASP technology to separate other isotopes in the future, which we believe have potential applications in the quantum computing target end market and nuclear green energy end market.
We were incorporated in Delaware in September 2021. Our principal executive offices are located at 1101 Pennsylvania Avenue NW, Suite 300, Washington, DC 20004, and our website address is www.aspisotopes.com.